OPPOSITION No B 2 589 581 Novartis AG., 4002 Basel, Switzerland (opponent), represented by Friedrich Graf von Westphalen & Partner mbB, Kaiser-Joseph-Str. 284, 79098 Freiburg i. Br., Germany (professional representative) a g a i n s t Stada Arzneimittel AG, Stadastr. 2-18, 61118 Bad Vilbel, Germany (applicant), represented by Harmsen Utescher, Neuer Wall 80, 20354 Hamburg, Germany (professional representative). On 10/01/2017,
OPPOSITION DIVISION OPPOSITION No B 2 414 822 Altia Consultores, S.A., Avenida del Pasaje 32, bloque 1, 2°,A-B, 15009 La Coruña, Spain (opponent), represented by Herrero & Asociados, Cedaceros, 1, 28014 Madrid, Spain (professional representative) a g a i n s t Novartis AG, 4002 Basel, Switzerland (applicant), represented by Friedrich Graf von Westphalen &
OPPOSITION No B 2 462 177 Boehringer Ingelheim International GmbH, 55218 Ingelheim, Germany (opponent) a g a i n s t Novartis AG, 4002 Basel, Switzerland (applicant) represented by Milojevic, Sekulic & Associates, S.L., C/ Clara Campoamor Num. 5 BW-107, 03540 Alicante, Spain (professional representative). On 30/05/2017, the Opposition Division takes the following
OPPOSITION No B 2 358 995 Novartis AG, 4002 Basel, Switzerland (opponent), represented by Friedrich Graf Von Westphalen & Partner mbB, Kaiser-Joseph-Str. 284, 79098 Freiburg i. Br., Germany (professional representative) a g a i n s t Mark Tarnopolsky, 19 Oakwood Place, Hamilton L8S 4C9, Canada (applicant), represented by Patentanwälte Bauer Vorberg Kayser Partnerschaft mbB, Goltsteinstr. 87, 50968 Köln,